DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	acemetacin	1981	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	acemetacin	1981	drug-path
Long-term potentiation	R-HSA-9620244	map04720	acemetacin	1981	drug-path
Gap junction	R-HSA-190861	map04540	acemetacin	1981	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	acemetacin	1981	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	acemetacin	1981	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	lysergol	3948	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	lysergol	3948	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	lysergol	3948	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	lysergol	3948	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	lysergol	3948	drug-path
Olfactory transduction	R-HSA-9751605	map04740	lysergol	3948	drug-path
Apoptosis	R-HSA-109581	map04210	lysergol	3948	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	lysergol	3948	drug-path
Asthma	R-HSA-444620	map05310	lysergol	3948	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	lysergol	3948	drug-path
Allograft rejection	R-HSA-9679028	map05330	lysergol	3948	drug-path
Colorectal cancer	R-HSA-4791275	map05210	lysergol	3948	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	lysergol	3948	drug-path
Olfactory transduction	R-HSA-9751605	map04740	3-nitropropionic acid	3326	drug-path